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NEURORADIOLOGY
Mas JL et al, for the EVA-3S Investigators. 
Hopitaux Sainte-Anne, Universite Rene Descartes, Paris, France. jl.mas@ch-sainte-anne.fr
Selected abstracts and commentary
New England Journal of Medicine 2006 Oct; 355:1660-1671.
BACKGROUND: Carotid stenting is less invasive than
endarterectomy, but it is unclear whether it is as safe in
patients with symptomatic carotid-artery stenosis. METHODS:
We conducted a multicenter, randomized, noninferiority trial to
compare stenting with endarterectomy in patients with a
symptomatic carotid stenosis of at least 60%. The primary end
point was the incidence of any stroke or death within 30 days
after treatment. RESULTS: The trial was stopped prematurely
after the inclusion of 527 patients for reasons of both safety
and futility. The 30-day incidence of any stroke or death was
3.9% after endarterectomy (95% confidence interval [CI], 2.0
to 7.2) and 9.6% after stenting (95% CI, 6.4 to 14.0); the
relative risk of any stroke or death after stenting as compared
with endarterectomy was 2.5 (95% CI, 1.2 to 5.1). The 30-day
incidence of disabling stroke or death was 1.5% after
endarterectomy (95% CI, 0.5 to 4.2) and 3.4% after stenting
(95% CI, 1.7 to 6.7); the relative risk was 2.2 (95% CI, 0.7 to
7.2). At 6 months, the incidence of any stroke or death was
6.1% after endar terectomy and 11.7% af ter  stenting
(P=0.02). There were more major local complications after
stenting and more systemic complications (mainly pulmonary)
after endarterectomy, but the differences were not significant.
Cranial-nerve injury was more common after endarterectomy
than after stenting. CONCLUSIONS: In this study of patients
ENDARTERECTOMY VERSUS STENTING IN PATIENTS WITH SYMPTOMATIC SEVERE CAROTID
STENOSIS
COMMENTARY
The neuroradiology highlights in this issue focus primarily on stroke intervention. Results of the EVA-3S trial came as a body
blow to individuals such as myself, who are proponents of carotid stenting. The trial, which compared the outcome in
symptomatic patients with atherosclerotic carotid artery disease undergoing carotid endarterectomy versus stenting, was
published in NEJM in October. It was prematurely stopped as the results in the endarterectomy group were significantly
better and it was felt that to carry on randomizing patients to stenting would be unethical. The conclusion is that in
symptomatic patients who are otherwise fit for surgery, endarterectomy is the treatment of choice.
The second abstract (Maleux et al) also points to the dangers of stenting, this time highlighting that distal protection
devices only give partial protection against embolic events. Using pre- and post-stenting diffusion-weighted images the
investigators found new ischemic foci in over 40% of patients undergoing stenting. Again, the conclusion being that stenting
should only be considered in patients either unable or unwilling to undergo endarterectomy.
Mechanical clot retrieval has been receiving a great deal of attention. One of the most widely used devices is the Merci
retriever. In a small study, Kim et al report its relative safety in a broad cohort of patients including patients failing
intravenous tPA and presenting outside the tPA window. With the development of safer devices along with evidence such as
this paper (and larger studies, e.g. the MERCI I & MERCI II trials), mechanical clot lysis and/or retrieval are becoming
acceptable therapies especially in patients with high scores on the NIH stroke scale.
The last abstract reinforces something that most of us already know: Vertebro-basilar occlusion is a bad disease. Patients
who failed recannalization with intra-arterial tPA did poorly, as did patients who had coma lasting more than 4.5 hours.
These patients need to be diagnosed quickly and managed aggressively.
Zafar Sajjad
Associate Professor of Radiology
Aga Khan University
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with symptomatic carotid stenosis of 60% or more, the rates of
death and stroke at 1 and 6 months were lower with
endarterectomy than with stenting. (ClinicalTrials.gov number:
NCT00190398 [ClinicalTrials.gov])
PURPOSE: Protected carotid artery stent placement is currently
under clinical evaluation as a potential alternative to carotid
endarterectomy. The current study was undertaken to
determine the incidence of new ischemic lesions found on
diffusion-weighted MR imaging (DWI) in nonselected patients
after protected carotid artery stent placement using a filter
device and to determine the potential relationship between
these new ischemic lesions and the presence or absence of a
clear amount of debris captured by the neuroprotection filter
device. MATERIALS AND METHODS: A nonrandomized cohort
of 52 patients (40 men, 12 women) presenting with carotid
occlusive disease underwent protected carotid artery stent
placement using a filter device. DWI obtained 1 day before
stent placement was compared with that obtained 1 day after
stent placement. In addition, the macroscopic and microscopic
analysis of debris captured by the filter device during the
carotid stent placement procedure was assessed. RESULTS:
Neuroprotected carotid stent placement was technically
successful in all 53 procedures but was complicated by a
transient ischemic attack in 3 patients (5.6%). In 22 patients
(41.5%), new ischemic lesions were found on DWI, and in 21
filter devices (39.6%), a substantial amount of atheromatous
plaque and/or fibrin was found. No clear relationship between
the presence of debris captured by the filter device and new
lesions detected by DWI was found (P = .087; odds ratio
3.067). CONCLUSION: Neuroprotected carotid artery stent
placement will not avoid silent cerebral ischemia. Systematic
microscopic analysis of debris captured by the filter device has
no predictive value for potential cerebral ischemia after carotid
artery stent placement.
Maleux G, Demaerel P, Verbeken E, Daenens K, Heye S, Van Sonhoven F, Nevelsteen A, Wilms G.
University of California at Los Angeles Stroke Center, Los Angeles, CA, USA. dkim@mednet.ucla.edu
American Journal of Neuroradiology 2006 Oct; 27:1830-1833
CEREBRAL ISCHEMIA AFTER FILTER-PROTECTED CAROTID ARTERY STENTING IS COMMON
AND CANNOT BE PREDICTED BY THE PRESENCE OF SUBSTANTIAL AMOUNT OF DEBRIS
CAPTURED BY THE FILTER DEVICE
BACKGROUND AND PURPOSE: Our aim was to describe an
expanded experience with endovascular mechanical
embolectomy in a broad group of patients, including those not
meeting entry criteria for the MERCI multicenter tr ials.
METHODS: We performed an analysis of all patients with
ischemic stroke treated with the Merci Clot Retrieval Device at
a single academic center outside of the Mechanical Embolus
Removal in Cerebral Ischemia (MERCI) trials. RESULTS:
Twenty-four patients were treated with the device. Nine were
MERCI trial ineligible: 4 received intravenous (IV) tissue
plasminogen activator (tPA), 1 received IV tPA and was
younger than 18 years of age, and 4 had time-to-treatment of
longer than 8 hours. Mean age was 64 years (range, 14-89
years; 42% women). Median National Institutes of Health
Stroke Scale (NIHSS) score was 21 (range, 11-30). Median
symptoms-to-procedure-start time was 303 minutes (range,
85-2385 minutes). Recanalization (Thrombolysis in Myocardial
Infarction, 2-3) was achieved in 15/24 (63%). In device-only
patients, recanalization occurred in 10/16. In patients who
failed IV tPA undergoing rescue embolectomy, recanalization
was achieved in 4/5. Three patients unresponsive to device
therapy received rescue int ra-ar terial  tPA/abcix imab;
recanalization was achieved in 2/3. Recanalization was
achieved in 3/4 patients in whom treatment was started longer
than 8 hours after symptom onset. Asymptomatic hemorrhage
occurred in 38%; symptomatic hemorrhage, in 8%. Three
device fractures occurred; none worsened clinical outcome. In-
hospital mortality was 17%; 90-day mortality, 29%. Good 90-
day functional outcome (modified Rankin Scale,  2) was
achieved by 25% (6/24). CONCLUSIONS: Endovascular
mechanical embolectomy is an effective means of achieving
revascularization in patients with acute ischemic stroke,
Kim D, Jahan R, Starkman S, Abolian A, Kidwell CS, Vinuela F, Duckwiler GR, Ovbiagele B, Vespa PM, Selco S,
Rajajee V, Saver JL.
University of California at Los Angeles Stroke Center, Los Angeles, CA, USA. dkim@mednet.ucla.edu
American Journal of Neuroradiology 2006 Nov-Dec; 27:2048-2052.
ENDOVASCULAR MECHANICAL CLOT RETRIEVAL IN A BROAD ISCHEMIC STROKE COHORT 
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including patients with late treatment start and intravenous tPA
failure. Device-based therapy achieved recanalization in nearly
two thirds of patients and good clinical outcomes in one fourth,
with symptomatic hemorrhage in less than one tenth.
BACKGROUND AND PURPOSE: To evaluate predictors of
recanalization and a favorable neurologic outcome in patients
with acute vertebrobasilar occlusion (VBO) treated with local
intra-arterial fibrinolysis (LIF). METHODS: The multicentric data
of 180 patients with acute VBO treated with LIF were
retrospectively evaluated. The modified Rankin scale (mRS)
was used to evaluate the neurologic status before LIF and at
the time of discharge. Patient's sex, age, etiology of VBO,
recanalization, symptom duration before LIF, and pretreatment
mRS were correlated with posttreatment mRS. Multiple logistic
regression analysis was used to identify independent variables
for recanalization and neurologic outcome. RESULTS: The
overall mortality was 43%. Complete recanalization was
achieved in 99 (55%) patients and a partial recanalization in
35 (19%) patients , respect ively . Recanalization was
significantly associated with a favorable outcome (P < .001).
The success of recanalization was negatively correlated with
the volume of the thrombus (P < .001). No correlation was
found between site and etiology of VBO and recanalization.
Neurologic outcome correlated strongly with the pretreatment
mRS (P < .001) and also with age (P < .02). Coma lasting
less than 4.5 hours led to a positive trend toward a better
outcome after univariate testing (P < .001). CONCLUSIONS:
Success of recanalization and neurologic status before
treatment predict neurologic outcome in patients with VBO.
Thrombus volume has an adverse effect on the recanalization
success
Schulte-Altedorneburg G, Hamann GF, Mull M, Kuhne D, Liebetrau M, Weber W, Bruckmann H, Mayer TE. 
Department of Neuroradiology, University of Munich, Klinikum Grosshadern, Germany. gernot.sad@gmx.de
American Journal of Neuroradiology 2006 Nov-Dec; 27:2042-2047.
OUTCOME OF ACUTE VERTEBROBASILAR OCCLUSIONS TREATED WITH INTRA-ARTERIAL
FIBRINOLYSIS IN 180 PATIENTS
